Caprock Group’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,251
Closed -$290K 1304
2026
Q1
$290K Buy
+5,251
New +$250K 0.01% 933
2018
Q4
Sell
-7,795
Closed -$334K 392
2018
Q3
$334K Hold
7,795
0.07% 250
2018
Q2
$359K Sell
7,795
-590
-7% -$26.1K 0.08% 242
2018
Q1
$333K Buy
8,385
+790
+10% +$29.3K 0.07% 249
2017
Q4
$271K Hold
7,595
0.05% 328
2017
Q3
$281K Hold
7,595
0.06% 311
2017
Q2
$281K Hold
7,595
0.06% 294
2017
Q1
$213K Buy
+7,595
New +$214K 0.05% 316

Other funds holding PAHC

Caprock Group's PAHC Position: Q2 2026 in Review

Caprock Group sold out of Phibro Animal Health (PAHC) in Q2 2026, closing a stake of 5,251 shares — an estimated $290K sold.

Caprock Group first reported a position in PAHC in Q1 2017 and held it in 8 quarters. The position peaked at $359K in Q2 2018. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Caprock Group reported no remaining Phibro Animal Health position as of Q2 2026 after selling out during the quarter.
  • Caprock Group sold 5,251 Phibro Animal Health shares in Q2 2026, an estimated $290K.
  • Caprock Group first reported a position in Phibro Animal Health in Q1 2017 and held it in 8 quarters.
  • Caprock Group's Phibro Animal Health position peaked at $359K in Q2 2018.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.